Cargando…

Sintilimab: Aggravation of Coronavirus disease 2019: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820096/ http://dx.doi.org/10.1007/s40278-021-90120-8

Ejemplares similares

Sintilimab: Pneumonitis: case report
Publicado: (2021)

Toxic Epidermal Necrolysis Induced by Sintilimab: A Case Report
por: Lye, Ya-lei, et al.
Publicado: (2023)

Sintilimab-induced autoimmune diabetes: A case report and review of the literature
por: Yang, Jing, et al.
Publicado: (2022)

EDP-M plus sintilimab in the treatment of adrenocortical carcinoma: a case report
por: Zhang, Zhipeng, et al.
Publicado: (2022)

Antineoplastics: Coronavirus disease-2019: case report
Publicado: (2020)

Immunosuppressants: Coronavirus disease-2019: case report
Publicado: (2020)

Prednisone: Coronavirus disease 2019: case report
Publicado: (2020)

Antineoplastics: Coronavirus disease 2019: case report
Publicado: (2022)

Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report
por: Zhong, Zhixian, et al.
Publicado: (2022)

Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review
por: Liu, Xin, et al.
Publicado: (2023)

Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events
por: Tu, Lingfang, et al.
Publicado: (2021)

Tozinameran: Aggravation of Crohn's disease: case report
Publicado: (2021)

Coronavirus disease 2019 and dengue: two case reports
por: Hilmy, Abdullah Isneen, et al.
Publicado: (2021)

Multiple drugs: Coronavirus disease-2019: case report
Publicado: (2021)

Immunosuppressants: Coronavirus disease 2019: 4 case reports
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Ocrelizumab: Coronavirus disease-2019 : 15 case reports
Publicado: (2022)

Immunosuppressants: Coronavirus disease of 2019: 3 case reports
Publicado: (2022)

Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
por: Zeng, Shu-Ying, et al.
Publicado: (2022)

Cytarabine/daunorubicin: Coronavirus disease-2019 pneumonia: case report
Publicado: (2021)

Doxorubicin: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2021)

Multiple drugs: Coronavirus disease 2019: 8 case reports
Publicado: (2021)

Multiple drugs: Coronavirus disease 2019: 25 case reports
Publicado: (2021)

Multiple drugs: Coronavirus disease-2019: 5 case reports
Publicado: (2021)

Adrenal insufficiency in coronavirus disease 2019: a case report
por: Heidarpour, Maryam, et al.
Publicado: (2020)

Alemtuzumab/methylprednisolone: Coronavirus disease-2019: 2 case reports
Publicado: (2020)

Belatacept: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2020)

Coronavirus disease 2019 presenting as psychosis: a case report
por: Lovi, Nyanyuie Kodjo, et al.
Publicado: (2022)

Natalizumab: Coronavirus disease-2019 infection: 6 case reports
Publicado: (2022)

Encephalomyelitis associated with coronavirus disease 2019: a case report
por: Estiasari, Riwanti, et al.
Publicado: (2022)

Pheochromocytoma triggered by coronavirus disease 2019: a case report
por: Naghshineh, Hoda, et al.
Publicado: (2022)

Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report
por: Lin, Sen, et al.
Publicado: (2022)

Adverse skin reactions induced by sintilimab in advanced lung squamous carcinoma: a case report and review of the literature
por: Yan, Juan, et al.
Publicado: (2022)

A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma
por: Gong, Yinhua, et al.
Publicado: (2023)

Death of a neonate with suspected coronavirus disease 2019 born to a mother with coronavirus disease 2019 in Iran: a case report
por: Rashidian, Tayebeh, et al.
Publicado: (2020)

Complete pathological response with diabetic ketoacidosis to the combination of sintilimab and anlotinib in an unresectable hepatocellular carcinoma patient: a case report
por: Fu, Lingli, et al.
Publicado: (2021)

Sintilimab-Induced Diabetic Ketoacidosis in a Patient with Radiation and Multichemorefractory Penile Cancer: A Case Report and Literature Review
por: Lv, Chuan, et al.
Publicado: (2022)

Necrotizing Skin Findings in Coronavirus Disease 2019: A Case Report
por: Çabuk, Fatmagül Kuşku, et al.
Publicado: (2021)

Challenges of dengue and coronavirus disease 2019 coinfection: two case reports
por: Agudelo Rojas, Olga Lucia, et al.
Publicado: (2021)

Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019
por: Melody, Megan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olg2ukjm4btghn2vddsldc5rbd